Plasticell appoints GSK's Aaron Chuang as chief scientific officer

Regenerative medicine company Pasticell has recruited Aaron Chuang as chief scientific officer.

Prior to this he was research director at the Regenerative Medicine unit of GlaxoSmithKline (LSE: GSK), where he worked for more than 18 years. Dr Chuang will take responsibility for Plasticell’s preclinical therapeutic programs, scientific oversight of collaborations and alliances, and external scientific communications.

Dr Chuang said: “I am delighted to be joining Plasticell, especially as I have followed closely the company and its innovative technologies for well over 10 years. Indeed, I have collaborated with Plasticell in a number of exciting initiatives including the spin-out of its sister company Progenitor Therapeutics. There is no doubt that Plasticell's CombiCult® is a game changer in our field and I look forward to helping the company leverage this ground-breaking technology across both cell therapy and cell manufacturing, as well as drug discovery and development.”